Morning Briefing
Summaries of health policy coverage from major news organizations
CDC Panel Will Meet Next Week To Consider Covid Booster Shots
The Hill: CDC Advisory Panel To Consider Third COVID-19 Shot For Immunocompromised
The Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel will consider a third COVID-19 shot for immunocompromised individuals. The panel will meet on July 22 to discuss “clinical considerations for additional doses in immunocompromised individuals,” the meeting’s agenda states. (Williams, 7/15)
CNBC: Some Portion Of The U.S. Population Will Get Booster Shots, Dr. Scott Gottlieb Says
Former Food and Drug Administration Commissioner Dr. Scott Gottlieb said Thursday that Covid booster shots may become a reality for certain swaths of the population. Gottlieb made the prediction on the heels of news that a panel of expert advisors to the Centers for Disease Control and Prevention plan to consider booster shots for immunocompromised patients. “I think the bottom line is that we’re going to be boosting some portion of the population,” Gottlieb told CNBC’s “The News with Shepard Smith.” “I think considering boosters, especially in the older, more vulnerable population, is something that we are going to have to do.” (DeCiccio, 7/15)
CNBC: Not Prudent To Deploy Vaccine Boosters At This Point: Ex-FDA Director
There isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director. “Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review. (Ng, 7/15)
Chicago Tribune: Some Who Got J&J COVID-19 Vaccines Seeking Booster Shots
Earlier this year, Erkin Peksoz wanted a COVID-19 vaccine so badly that he drove 640 miles roundtrip from Chicago to Quincy to get a Johnson & Johnson shot. Peksoz was happy with that decision — until recently, when the more contagious delta variant of the virus emerged. Now, he’d like to get a shot of a Moderna or Pfizer vaccine, in hopes of increasing his protection. (Schencker, 7/15)
